Skip to main content
Ainos, Inc. logo

Ainos, Inc. — Investor Relations & Filings

Ticker · AIMD ISIN · US00902F3038 LEI · 549300AX97HS3UDQ2Y10 US Professional, scientific and technical activities
Filings indexed 992 across all filing types
Latest filing 2026-01-30 Major Shareholding Noti…
Country US United States of America
Listing US AIMD

About Ainos, Inc.

https://www.ainos.com/

Ainos, Inc. is a diversified medical technology company that integrates artificial intelligence with biotechnology to develop diagnostic and therapeutic solutions. A core focus is its proprietary "AI Nose" platform, a SmellTech technology that utilizes AI and advanced sensor arrays to detect and analyze Volatile Organic Compounds (VOCs) for diagnostic applications. In parallel, the company develops immune therapeutics, leveraging its extensive experience with low-dose interferon treatments and advancing SRNA-driven preventative medicine. Ainos also develops telehealth-compatible point-of-care testing (POCT) devices.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-30 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-01-30 English
4 Filing
Director's Dealing
2026-01-29 English
SCHEDULE 13D Filing
Major Shareholding Notification
2026-01-27 English
4 Filing
Director's Dealing
2026-01-12 English
8-K Filing
Regulatory Filings
2026-01-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.